Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 77.83B | 77.83B | 68.35B | 62.98B | 56.39B | 39.61B |
Gross Profit | 36.48B | 31.55B | 22.95B | 35.31B | 42.21B | 21.17B |
EBITDA | 16.00B | 15.88B | 13.07B | 12.29B | 14.03B | 4.44B |
Net Income | 7.74B | 7.74B | 5.99B | 5.89B | 5.55B | -1.10B |
Balance Sheet | ||||||
Total Assets | 136.92B | 136.92B | 132.89B | 124.34B | 118.85B | 111.55B |
Cash, Cash Equivalents and Short-Term Investments | 5.08B | 5.08B | 6.00B | 3.94B | 4.13B | 4.16B |
Total Debt | 24.75B | 24.75B | 11.55B | 9.26B | 12.55B | 15.31B |
Total Liabilities | 45.22B | 45.22B | 47.33B | 43.33B | 48.76B | 44.37B |
Stockholders Equity | 89.17B | 89.17B | 76.63B | 72.42B | 61.78B | 61.20B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 5.77B | 1.58B | 3.75B | 6.50B | 2.67B |
Operating Cash Flow | 0.00 | 14.24B | 11.00B | 8.22B | 8.65B | 4.85B |
Investing Cash Flow | 0.00 | -7.79B | -9.21B | -3.74B | -5.14B | -1.35B |
Financing Cash Flow | 0.00 | -7.14B | -864.58M | -4.71B | -5.17B | -1.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ₹688.22B | 79.24 | 0.11% | 14.04% | 32.99% | ||
73 Outperform | ₹1.09T | 69.51 | 0.25% | 14.31% | 51.71% | ||
70 Outperform | ₹274.05B | 52.46 | 0.74% | 10.57% | 34.11% | ||
66 Neutral | ₹1.02T | 53.06 | 0.04% | 21.66% | -4.92% | ||
66 Neutral | ₹358.11B | 45.38 | 0.25% | 12.09% | -2.79% | ||
64 Neutral | ₹113.57B | 72.79 | 0.71% | 12.86% | 10.42% | ||
51 Neutral | $7.86B | -0.33 | -41.57% | 2.23% | 23.26% | -2.03% |
Fortis Healthcare Limited has reported details of its debt securities issued through private placement, as per the SEBI Master Circular. The company has issued debt securities amounting to a total of 1,550 Crore INR, with a coupon rate of 8.486% for the first year, which will be reset annually. This announcement is significant for stakeholders as it reflects Fortis Healthcare’s financial strategies and commitments in the debt market, potentially impacting its financial stability and market positioning.